Clinical Trials Browser

Phase 2 × Birt-Hogg-Dube Syndrome × Everolimus × Clear all

NCT02504892 2019-03-22

Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer

Phase 2 Terminated

3 enrolled 7 charts

Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Birt-Hogg-Dube Syndrome